Nora Janjan

Articles in Scholarly Journals [Incomplete List]

  1. Role of Adjuvant Chemoradiation Therapy in Adenocarcinomas of the Ampulla of Vater
    International Journal of Radiation OncologyBiologyPhysics, vol. 70, no. 3, pp. 735–743, 2008
  2. Chemoradiation Therapy for Potentially Resectable Gastric Cancer: Clinical Outcomes Among Patients Who Do Not Undergo Planned Surgery
    International Journal of Radiation OncologyBiologyPhysics, vol. 71, no. 1, pp. 167–172, 2008
  3. Patterns of Locoregional Recurrence After Surgery and Radiotherapy or Chemoradiation for Rectal Cancer
    International Journal of Radiation OncologyBiologyPhysics, vol. 71, no. 4, pp. 1175–1180, 2008
  4. Clinical benefit of palliative radiation therapy in advanced gastric cancer
    Acta Oncologica, vol. 47, no. 3, pp. 421–427, 2008
  5. Incidence, Natural History, and Patterns of Locoregional Recurrence in Gastric Cancer Patients Treated with Preoperative Chemoradiotherapy
    International Journal of Radiation OncologyBiologyPhysics, 2007
  6. Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal Cancer
    International Journal of Radiation OncologyBiologyPhysics, vol. 68, no. 3, pp. 794–800, 2007
  7. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer
    Cancer, vol. 109, no. 9, pp. 1750–1755, 2007
  8. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy
    Cancer, vol. 110, no. 1, pp. 47–55, 2007
  9. Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction
    Annals of Surgical Oncology, vol. 14, no. 7, pp. 2010–2017, 2007
  10. Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction
    Annals of Surgical Oncology, vol. 14, no. 4, pp. 1305–1311, 2007
  11. Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer
    American Journal of Clinical Oncology, vol. 29, no. 3, pp. 219–224, 2006
  12. Retrospective Study of Capecitabine and Celecoxib In Metastatic Colorectal Cancer
    American Journal of Clinical Oncology, vol. 29, no. 3, pp. 232–239, 2006
  13. Conformal Radiotherapy of the Dominant Liver Metastasis
    American Journal of Clinical Oncology, vol. 29, no. 6, pp. 562–567, 2006
  14. Radiation Oncology, vol. 1, no. 1, p. 41, 2006
  15. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation
    Cancer, vol. 107, no. 11, pp. 2589–2596, 2006
  16. Palliation and Supportive Care in Radiation Medicine
    Hematology/Oncology Clinics of North America, vol. 20, no. 1, pp. 187–211, 2006
  17. Continuing evidence for poorer treatment outcomes for single male patients: Retreatment data from RTOG 97-14
    International Journal of Radiation Oncology*Biology*Physics, vol. 66, no. 1, pp. 229–233, 2006
  18. Phase II study of capecitabine (Xeloda®) and concomitant boost radiotherapy in patients with locally advanced rectal cancer
    International Journal of Radiation OncologyBiologyPhysics, vol. 66, no. 3, pp. 762–771, 2006
  19. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis
    International Journal of Radiation OncologyBiologyPhysics, vol. 66, no. 5, pp. 1378–1383, 2006
  20. Outcome After Curative Resection for Locally Recurrent Rectal Cancer
    Diseases of the Colon & Rectum, vol. 49, no. 2, pp. 175–182, 2006
  21. Update in Cancer Pain Syndromes
    Journal of Palliative Medicine, vol. 9, no. 6, pp. 1414–1434, 2006
  22. Regional Cancer Pain Syndromes
    Journal of Palliative Medicine, vol. 9, no. 6, pp. 1435–1453, 2006
  23. Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases
    CancerSpectrum Knowledge Environment, vol. 97, no. 11, pp. 798–804, 2005
  24. Do we need to improve pain management in the radiation oncology department?
    Nature Clinical Practice Oncology, vol. 2, no. 3, Article ID ncponc0111, 1 pages, 2005
  25. Paclitaxel-Based Chemoradiotherapy in Localized Gastric Carcinoma: Degree of Pathologic Response and Not Clinical Parameters Dictated Patient Outcome
    Journal of Clinical Oncology, vol. 23, no. 6, pp. 1237–1244, 2005
  26. Multi-Institutional Trial of Preoperative Chemoradiotherapy in Patients With Potentially Resectable Gastric Carcinoma
    Journal of Clinical Oncology, vol. 22, no. 14, pp. 2774–2780, 2004
  27. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients
    International Journal of Radiation Oncology*Biology*Physics, vol. 60, no. 4, pp. 1098–1105, 2004
  28. American Society for Therapeutic Radiology and Oncology and American College of Radiology Practice Guideline for the Performance of Stereotactic Body Radiation Therapy
    International Journal of Radiation OncologyBiologyPhysics, vol. 60, no. 4, pp. 1026–1032, 2004
  29. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma
    Journal of Gastrointestinal Surgery, vol. 8, no. 1, pp. 56–63, 2004
  30. Combined-modality therapy for gastric cancer
    Seminars in Surgical Oncology, vol. 21, no. 4, pp. 223–227, 2003
  31. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma
    Cancer, vol. 97, no. 2, pp. 517–524, 2003
  32. Cisplatin-based combined modality therapy for anal carcinoma
    Cancer, vol. 97, no. 5, pp. 1195–1202, 2003
  33. Initial Experience Combining Cyclooxygenase-2 Inhibition with Chemoradiation for Locally Advanced Pancreatic Cancer
    American Journal of Clinical Oncology, vol. 26, no. Supplement 2, pp. S81–S84, 2003
  34. Chemoradiation for adenocarcinoma of the anus
    International Journal of Radiation Oncology*Biology*Physics, vol. 55, no. 3, pp. 669–678, 2003
  35. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer1
    International Journal of Radiation OncologyBiologyPhysics, vol. 57, no. 1, pp. 84–89, 2003
  36. Roles and responsibilities of specialists involved in coronary artery radiation therapy (CART) and the CART procedure
    International Journal of Radiation Oncology*Biology*Physics, vol. 57, no. 1, pp. 6–8, 2003
  37. American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer
    Journal of Clinical Oncology, vol. 21, no. 21, pp. 4042–4057, 2003
  38. Pain and Quality of Life After Treatment in Patients With Locally Recurrent Rectal Cancer
    Journal of Clinical Oncology, vol. 20, no. 21, pp. 4361–4367, 2002
  39. Preoperative Paclitaxel and Concurrent Rapid-Fractionation Radiation for Resectable Pancreatic Adenocarcinoma: Toxicities, Histologic Response Rates, and Event-Free Outcome
    Journal of Clinical Oncology, vol. 20, no. 10, pp. 2537–2544, 2002
  40. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
    International Journal of Radiation Oncology*Biology*Physics, vol. 52, no. 5, pp. 1293–1302, 2002
  41. Limitations of conventional doses of chemoradiation for unresectable biliary cancer
    International Journal of Radiation Oncology*Biology*Physics, vol. 53, no. 4, pp. 969–974, 2002
  42. American Journal of Clinical Oncology, vol. 25, no. 1, pp. 9–15, 2002
  43. American Journal of Clinical Oncology, vol. 24, no. 2, pp. 107–112, 2001
  44. Bone metastases: Approaches to management
    Seminars in Oncology, vol. 28, pp. 28–34, 2001
  45. Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer1
    International Journal of Radiation OncologyBiologyPhysics, vol. 49, no. 1, pp. 107–116, 2001
  46. The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas
    International Journal of Radiation Oncology*Biology*Physics, vol. 49, no. 4, pp. 1033–1043, 2001
  47. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment1
    International Journal of Radiation OncologyBiologyPhysics, vol. 51, no. 1, pp. 176–183, 2001
  48. Elective groin irradiation is not indicated for patients with adenocarcinoma of the rectum extending to the anal canal
    International Journal of Radiation OncologyBiologyPhysics, vol. 51, no. 3, pp. 741–747, 2001
  49. Phase I Study of Concomitant Gemcitabine and IMRT for Patients with Unresectable Adenocarcinoma of the Pancreatic Head
    International Journal of Gastrointestinal Cancer, vol. 30, no. 3, pp. 123–132, 2001
  50. Investigational New Drugs, vol. 18, no. 1, pp. 43–56, 2000
  51. Cancer pain management by radiotherapists: a survey of radiation therapy oncology group physicians
    International Journal of Radiation Oncology*Biology*Physics, vol. 47, no. 1, pp. 203–208, 2000
  52. Avoidance of Colostomy Placement in Advanced Colorectal Cancer with Twice Weekly Hypofractionated Radiation Plus Continuous Infusion 5-Fluorouracil
    Journal of Pain and Symptom Management, vol. 20, no. 4, pp. 266–272, 2000
  53. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer
    International Journal of Radiation Oncology*Biology*Physics, vol. 47, no. 3, pp. 713–718, 2000
  54. Optimization of beam orientations and weights for coplanar conformal beams in treating pancreatic cancer
    Medical Dosimetry, vol. 24, no. 4, pp. 265–271, 1999
  55. American Journal of Dermatopathology, vol. 21, no. 1, pp. 28–30, 1999
  56. Sacral Chordoma: 40-Year Experience at a Major Cancer Center
    Neurosurgery, vol. 44, no. 1, pp. 74–79, 1999
  57. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer
    Radiotherapy and Oncology, vol. 51, no. 2, pp. 153–160, 1999
  58. Role of radiotherapy in sarcoma of the breast – a retrospective review of the M.D. Anderson experience
    Radiotherapy and Oncology, vol. 52, no. 2, pp. 173–178, 1999
  59. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience
    International Journal of Radiation OncologyBiologyPhysics, vol. 44, no. 5, pp. 1027–1038, 1999
  60. Predictors of Recurrence After Local Excision and Postoperative Chemoradiation Therapy of Adenocarcinoma of the Rectum
    Annals of Surgical Oncology, vol. 6, no. 1, pp. 26–32, 1999
  61. Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas
    Journal of Hepato-Biliary-Pancreatic Surgery, vol. 5, no. 3, pp. 242–250, 1998
  62. World conference for cancer organisations march 3-7, 1996, melbourne, australia
    Cancer, vol. 82, no. 1, pp. 234–234, 1998
  63. Primary pancreatic lymphoma?
    Surgery, vol. 123, no. 4, pp. 382–390, 1998
  64. Mammography in the Evaluation of Masses in Breasts Reconstructed with TRAM Flaps
    Annals of Plastic Surgery, vol. 41, no. 3, p. 234, 1998
  65. American Journal of Clinical Oncology, vol. 21, no. 1, pp. 28–30, 1998
  66. Presenting Symptoms in Patients Referred to a Multidisciplinary Clinic for Bone Metastases
    Journal of Pain and Symptom Management, vol. 16, no. 3, pp. 171–178, 1998
  67. Teaching cancer pain management: durability of educational effects of a role model program
    Cancer, vol. 77, no. 5, pp. 996–1001, 1996
  68. Postoperative radiotherapy for locally advanced colon cancer
    Annals of Surgical Oncology, vol. 3, no. 5, pp. 421–422, 1996
  69. Radiotherapeutic management of spinal metastases
    Journal of Pain and Symptom Management, vol. 11, no. 1, pp. 47–56, 1996
  70. Evaluation and scoring of radiotherapy treatment plans using an artificial neural network
    International Journal of Radiation Oncology*Biology*Physics, vol. 34, no. 4, pp. 923–930, 1996
  71. Reply to Leith
    International Journal of Radiation Oncology*Biology*Physics, vol. 31, no. 3, p. 690, 1995
  72. Closure of Massive Chest Wall Defects After Full-Thickness Chest Wall Resection
    Annals of Plastic Surgery, vol. 34, no. 4, pp. 409–414, 1995
  73. Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children
    Otolaryngology - Head and Neck Surgery, vol. 112, no. 2, pp. 252–257, 1995
  74. Immediate versus delayed free-tissue transfer salvage of the lower extremity in soft tissue sarcoma patients
    Annals of Surgical Oncology, vol. 1, no. 1, pp. 11–17, 1994
  75. Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation
    Annals of Surgical Oncology, vol. 1, no. 5, pp. 415–422, 1994
  76. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater results of radiation therapy oncology group 85–28
    Cancer, vol. 71, no. 4, pp. 1362–1367, 1993
  77. Cardiac doses in post-operative breast irradiation by fuller et al.
    Radiotherapy and Oncology, vol. 27, no. 1, p. 77, 1993
  78. An updated dose-response analysis in Hodgkin's disease by S. Vijayakumar and L.C. Myrianthopoulous
    Radiotherapy and Oncology, vol. 27, no. 1, pp. 80–81, 1993
  79. Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer
    Cancer, vol. 69, no. 11, pp. 2842–2848, 1992
  80. Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases
    Journal of Neuro-Oncology, vol. 11, no. 3, pp. 235–239, 1991
  81. Is the dose-response relationship for local control of Hodgkin's disease obscured by lung inhomogeneity corrections?
    Radiotherapy and Oncology, vol. 22, no. 3, pp. 195–200, 1991
  82. Radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: A review of recent techniques
    Cancer Treatment Reviews, vol. 17, no. 1, pp. 89–101, 1990
  83. Assessment of pain during head and neck irradiation
    Journal of Pain and Symptom Management, vol. 4, no. 2, pp. 90–95, 1989
  84. Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease
    Cancer, vol. 61, no. 2, pp. 252–254, 1988
  85. Management of locoregional recurrent breast cancer
    Cancer, vol. 58, no. 7, pp. 1552–1556, 1986